US20110123543A1 - TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease - Google Patents

TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease Download PDF

Info

Publication number
US20110123543A1
US20110123543A1 US12/583,851 US58385109A US2011123543A1 US 20110123543 A1 US20110123543 A1 US 20110123543A1 US 58385109 A US58385109 A US 58385109A US 2011123543 A1 US2011123543 A1 US 2011123543A1
Authority
US
United States
Prior art keywords
tnf
anti
patients
antibody
ca2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/583,851
Inventor
Marc Feldmann
Ravinder N. Maini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kennedy Mathilda and Terence Institute of Rheumatology Trust
Original Assignee
Kennedy Mathilda and Terence Institute of Rheumatology Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US95824892A priority Critical
Priority to PCT/GB1993/002070 priority patent/WO1994008619A1/en
Priority to US08/403,785 priority patent/US5741488A/en
Priority to PCT/GB1994/000462 priority patent/WO1995009652A1/en
Priority to US60741996A priority
Priority to US08/690,775 priority patent/US6270766B1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24773909&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20110123543(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US09/754,004 priority patent/US20020010180A1/en
Priority to US11/225,631 priority patent/US7846442B2/en
Application filed by Kennedy Mathilda and Terence Institute of Rheumatology Trust filed Critical Kennedy Mathilda and Terence Institute of Rheumatology Trust
Priority to US12/583,851 priority patent/US20110123543A1/en
Publication of US20110123543A1 publication Critical patent/US20110123543A1/en
Application status is Abandoned legal-status Critical

Links